Classification of amyloid fibril proteins and their precursors: An ongoing discussion

Amyloid

Volumn 4, Issue 3, 1997, Pages 216-218

  Westermark, Per ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85017204082     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129709014387     Document Type: Editorial

References (12)

1. Cohen A S, Franklin E C, Glenner G G, Natvig J B, Osserman E F, Wegelius O. Nomenclature. Amyloidosis, O Wegelius, A Pasternack. Academic Press, London 1976; IX
2. Benditt E P, Cohen A S, Costa P P, Franklin E C, Glenner G G, Husby G, Mandema E, Natvig J B, Osserman E F, Sohar E, Wegelius O, Westermark P. Guidelines for nomenclature. Amyloid and Amyloidosis, G G Glenner, P P Costa, A F Freitas. Excerpta Medica, Amsterdam 1980; XI – XII
3. Husby G, Araki S, Benditt E P, Benson M D, Cohen A S, Frangione B, Glenner G G, Natvig J B, Westermark P. The 1990 guidelines for nomenclature and classification of amyloid and amyloidosis. Amyloid and Amyloidosis 1990, J B Natvig, Ø Forre, G Husby, A Husebekk, B Skogen, K Sletten, P Westermark. Kluwer, Dordrecht 1991; 7 – 11
4. Sipe J D. Serum amyloid A protein classification: A preliminary report of a subcommittee of the International Society of Amyloidosis. Amyloid: Int J Exp Clin Invest 1995; 2: 69 – 79
5. Glenner G G, Wong C W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984; 120: 885 – 890
6. Masters C, Simms G, Weinman N A, Multhaup G, McDonald B L, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Nall Acad Sci USA 1985; 82: 4245 – 4249
7. Beaudet A L, Tsui L-C. A suggested nomenclature for designating mutations. Hum Mut 1993; 2: 245 – 248
8. Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfelt L. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nature Genet 1992; 1: 345 – 347
9. Johnson K H, Westermark P, Sletten K, O'Brien T D. Amyloid proteins and amyloidosis in domestic animals. Amyloid: Int J Exp Clin Invest 1996; 3: 270 – 289
10. Naiki, Kitado H, Hosokawa M. Accelerated senile amyloidosis induced by amyloidogenic ApoA-II gene shortens the life span of mice but does not accelerate the rate of senescence. J Gerontol 1996; 51: B295 – B302
11. Baumann M H, Wisniewski T, Levy E, Plant G T, Ghiso J. C-terminal fragments of alpha-and beta-tubulin form amyloid fibrils in vitro and associate with amyloid deposits of familial cerebral amyloid angiopathy, British type. Biochem Biophys Res Commun 1996; 219: 238 – 242
12. Dische F E, Wernstedt C, Westermark G T, Westermark P, Pepys M B, Rennie J A, Gilbey S G, Watkins P J. Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient. Diabetologia 1988; 31: 158 – 161